|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001347,
umls-concept:C0002721,
umls-concept:C0019158,
umls-concept:C0026809,
umls-concept:C0036825,
umls-concept:C0036974,
umls-concept:C0151799,
umls-concept:C0205164,
umls-concept:C0205227,
umls-concept:C0683598,
umls-concept:C1314939,
umls-concept:C1456820
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2000-9-8
|
|
pubmed:abstractText |
The proinflammatory cytokine tumor necrosis factor alpha (TNF-alpha) induces lethal hepatitis when injected into D-(+)-galactosamine-sensitized mice on the one hand or systemic inflammatory response syndrome (SIRS) in normal mice on the other hand. We studied whether serum amyloid P component (SAP), the major acute-phase protein in mice, plays a protective role in both lethal models. For this purpose, we used SAP(0/0) mice generated by gene targeting. We studied the lethal response of SAP(0/0) or SAP(+/+) mice to both lethal triggers but found no differences in the sensitivity of both types of mice. We also investigated whether SAP is involved in establishing two types of endogenous protection: one using a single injection of interleukin-1beta (IL-1beta) for desensitization and clearly involving a liver protein, the other by tolerizing mice for 5 days using small doses of human TNF-alpha. Although after IL-1beta or after tolerization the SAP levels in the serum had risen fourfold in the control mice and not in the SAP(0/0) mice, the same extents of desensitization and tolerization were achieved. Finally, we observed that the induction of hemorrhagic necrosis in the skin of mice by two consecutive local injections with TNF-alpha was not altered in SAP(0/0) mice. We conclude that the presence or absence of SAP has no influence on the sensitivity of mice to TNF-alpha-induced hepatitis, SIRS, and hemorrhagic necrosis or on the endogenous protective mechanisms of desensitization or tolerization.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-1431140,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-1526624,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-1657127,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-1727926,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-1826631,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-1849935,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-2037372,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-2170518,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-2361734,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-2464504,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-2472090,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-2701729,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-2924376,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-3056630,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-3105045,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-3258889,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-3422444,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-3819645,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-423976,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-4375846,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-7522168,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-7592941,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-7768358,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-7895325,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-7931089,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8046244,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8114934,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8280464,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8393897,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8417122,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8429642,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8452873,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8520688,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8791740,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8847144,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-8943423,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-9256275,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-9317155,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-9794839,
http://linkedlifedata.com/resource/pubmed/commentcorrection/10948120-9854502
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0019-9567
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5026-9
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:10948120-Animals,
pubmed-meshheading:10948120-Galactosamine,
pubmed-meshheading:10948120-Hepatitis, Animal,
pubmed-meshheading:10948120-Interleukin-1,
pubmed-meshheading:10948120-Mice,
pubmed-meshheading:10948120-Mice, Inbred C57BL,
pubmed-meshheading:10948120-Necrosis,
pubmed-meshheading:10948120-Serum Amyloid P-Component,
pubmed-meshheading:10948120-Skin,
pubmed-meshheading:10948120-Systemic Inflammatory Response Syndrome,
pubmed-meshheading:10948120-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
The major acute-phase protein, serum amyloid P component, in mice is not involved in endogenous resistance against tumor necrosis factor alpha-induced lethal hepatitis, shock, and skin necrosis.
|
|
pubmed:affiliation |
Department of Molecular Biology, Flanders Interuniversity Institute for Biotechnology and University of Ghent, B-9000 Ghent, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
